Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Chaser Therapeutics identifies new USP28 and USP25 inhibitors

Nov. 27, 2020

TYK Medicines divulges protein kinase inhibitors

Nov. 27, 2020

Senhwa files INDs in U.S. and Canada to study CX-5461 for solid tumors with BRCA2 or PALB2 mutations

Nov. 26, 2020

Karyopharm presents phase III data from SEAL study of Xpovio in liposarcoma

Nov. 26, 2020

Health Canada approves Lynparza as treatment of BRCA or ATM gene-mutated mCRPC

Nov. 26, 2020

Chinese approval for phase I/II study of ATG-016 for MDS

Nov. 26, 2020

Incyte synthesizes CDK2/cyclin E inhibitors

Nov. 26, 2020

Constellation Pharmaceuticals synthesizes TREX1 inhibitors

Nov. 26, 2020

Kinnate Biopharma patents Raf kinase inhibitors

Nov. 26, 2020

Final phase I/II data for PLX-9486 plus sunitinib in GIST

Nov. 25, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...